- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made).
25.—(1) The 2004 Act is amended as follows.
(2) In section 14(1) (remit)—
(a)in subsection (1) after paragraph (h) insert—
“(i)the donation, testing, characterisation, procurement, preservation, transport, transplantation and disposal of human organs, in so far as those activities are activities to which regulation 5(1) of the 2012 Regulations applies and are not within the remit of the Authority by virtue of paragraphs (a) to (h).”; and
(b)after subsection (2A) insert—
“(2B) Expressions used in paragraph (i) of subsection (1) and in the 2012 Regulations have the same meaning in that paragraph as in those Regulations.”.
(3) In section 32 (prohibition of commercial dealings in human material for transplantation), after subsection (3) insert—
“(3A) The Authority may not designate a person under subsection (3) to engage in any activity relating to an organ (within the meaning given by Directive 2010/53/EU of the European Parliament and of the Council on standards of quality and safety of human organs intended for transplantation) for use for the purpose of transplantation.”.
(4) In section 41(1)(2) (interpretation of Part 2), after the definition of “the 2007 Regulations” insert—
““the 2012 Regulations” means the Quality and Safety of Organs Intended for Transplantation Regulations 2012;”.
(5) In section 59(4) (provisions extending to Scotland)—
(a)before paragraph (a) insert—
“(za)section 13,”; and
(b)in paragraph (f), after “and 61,” insert—
“(fa)Schedule 2,”.
(6) In Schedule 2(3) (the Human Tissue Authority), at the end of paragraph 1 (membership), insert—
“(3) The Scottish Ministers may nominate a person who is a member of the Authority to make representations about the carrying out of its functions in Scotland.”.
(7) In Schedule 3(4) (licences for the purposes of section 16), in paragraph 13 (applications under this Schedule), in sub-paragraph (1), for “and Schedule 1 to the 2007 Regulations” substitute “, Schedule 1 to the 2007 Regulations and Schedule 1 to the 2012 Regulations”.
Amended by the Human Fertilisation and Embryology Act 2008 (c.22), Schedule 7, paragraph 23 and by S.I. 2007/1523.
Amended by S.I. 2007/1523.
Amended by the Health Act 2009 (c.21), Schedule 3, Part 1, paragraph 7.
Amended by S.I. 2007/1523.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: